Semaglutide is a GLP-1 receptor agonist with no direct action on renal potassium handling or cellular potassium distribution
Asimismo, se pide no utilizar el frmaco si quien lo va a consumir, o un familiar, ha tenido carcinoma medular de tiroides o el sndrome de neoplasia endocrina mltiple tipo 2
The small increase in heart rate observed with semaglutide (approximately 2-3 beats per minute on average) is documented in the SmPC
That said, its important to be aware of the activities a person engages in when they travele.g., if they are on a strenuous hike, they are likely burning more calories than usual, so they should make sure to keep snacks on hand to avoid low blood sugar episodes
Among them, 579,589 patients (15.1%) had been prescribed a GLP-1 RA: Dulaglutide: 6.6% Semaglutide: 4.9% Liraglutide: 4.2% Exenatide: 2.1% To control for disease severity, patients using only metformin or insulin were excluded from the primary reference group